lobbying_activities: 3140332

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3140332	81200c7b-fdd6-48c2-8d53-5026afdd1dc8	Q1	INLET STRATEGIES	401106604	COHERUS BIOSCIENCES, INC	2024	first_quarter	MMM	S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to reform of pharmacy benefit managers Issues related to drug shortages and the pharmaceutical supply chainS. S. 1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office	45000		0	0	2024-04-07T19:05:49-04:00